Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences
J Bras Nefrol. 2023 Jul-Sep;45(3):274-276.
doi: 10.1590/2175-8239-JBN-2023-E012en.
[Article in
English,
Portuguese]
Affiliation
- 1 Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Pediatria: Nefrologia Pediátrica, Campinas, SP, Brazil.
No abstract available
MeSH terms
-
Humans
-
Immunosuppressive Agents
-
Nephrosis, Lipoid*
-
Nephrotic Syndrome* / drug therapy
-
Recurrence
-
Rituximab / therapeutic use
-
Treatment Outcome
Substances
-
Rituximab
-
Immunosuppressive Agents